Thrivent Financial for Lutherans Increases Stake in Tema Oncology ETF (NASDAQ:CANC)

Thrivent Financial for Lutherans increased its stake in Tema Oncology ETF (NASDAQ:CANC) by 25.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 399,509 shares of the company’s stock after acquiring an additional 80,133 shares during the period. Thrivent Financial for Lutherans owned approximately 0.23% of Tema Oncology ETF worth $11,351,000 as of its most recent SEC filing.

Tema Oncology ETF Trading Up 0.8 %

CANC stock opened at $26.52 on Friday. The company has a market cap of $46.15 million, a PE ratio of 26.86 and a beta of 1.11. The stock has a 50-day moving average price of $28.09 and a two-hundred day moving average price of $28.10. Tema Oncology ETF has a 12-month low of $22.90 and a 12-month high of $30.11.

About Tema Oncology ETF

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.